CN105287787A - 治疗直肠痔疮脱垂回托散及制备方法 - Google Patents
治疗直肠痔疮脱垂回托散及制备方法 Download PDFInfo
- Publication number
- CN105287787A CN105287787A CN201510911960.8A CN201510911960A CN105287787A CN 105287787 A CN105287787 A CN 105287787A CN 201510911960 A CN201510911960 A CN 201510911960A CN 105287787 A CN105287787 A CN 105287787A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- hemorrhoid
- alumen
- proctoptosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 56
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 53
- 208000012287 Prolapse Diseases 0.000 title abstract description 10
- 210000000664 rectum Anatomy 0.000 title abstract description 6
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 22
- 241000237858 Gastropoda Species 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000005406 washing Methods 0.000 claims abstract description 5
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract description 4
- 244000293323 Cosmos caudatus Species 0.000 claims description 20
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 241001523405 Limax Species 0.000 claims description 13
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 10
- 244000025254 Cannabis sativa Species 0.000 claims description 8
- 230000004308 accommodation Effects 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 206010053615 Thermal burn Diseases 0.000 claims description 3
- 230000007423 decrease Effects 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims description 2
- 239000000571 coke Substances 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 238000013461 design Methods 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 33
- 208000002193 Pain Diseases 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 4
- 229940037003 alum Drugs 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 240000003152 Rhus chinensis Species 0.000 abstract description 2
- 235000014220 Rhus chinensis Nutrition 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 abstract 1
- 241000759909 Camptotheca Species 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 241001278833 Rosa laevigata Species 0.000 abstract 1
- 235000000661 Rosa laevigata Nutrition 0.000 abstract 1
- 244000082946 Tarchonanthus camphoratus Species 0.000 abstract 1
- 235000005701 Tarchonanthus camphoratus Nutrition 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 230000009471 action Effects 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 208000025865 Ulcer Diseases 0.000 description 7
- 210000000436 anus Anatomy 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000035861 hematochezia Diseases 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 102000019197 Superoxide Dismutase Human genes 0.000 description 5
- 108010012715 Superoxide dismutase Proteins 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 210000004877 mucosa Anatomy 0.000 description 5
- 231100000019 skin ulcer Toxicity 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000000507 anthelmentic effect Effects 0.000 description 4
- 230000001142 anti-diarrhea Effects 0.000 description 4
- 208000002399 aphthous stomatitis Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 210000002460 smooth muscle Anatomy 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- REZQBEBOWJAQKS-UHFFFAOYSA-N triacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO REZQBEBOWJAQKS-UHFFFAOYSA-N 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 206010046814 Uterine prolapse Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 208000019902 chronic diarrheal disease Diseases 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 3
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- IOIGOIPHPUCFOB-IMTBSYHQSA-N (6r,7s)-7-methyl-6,7-dihydro-5h-cyclopenta[c]pyridin-6-ol Chemical compound C1=NC=C2[C@H](C)[C@H](O)CC2=C1 IOIGOIPHPUCFOB-IMTBSYHQSA-N 0.000 description 2
- HAWSQZCWOQZXHI-FQEVSTJZSA-N 10-Hydroxycamptothecin Chemical compound C1=C(O)C=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 HAWSQZCWOQZXHI-FQEVSTJZSA-N 0.000 description 2
- KLFJSYOEEYWQMR-NRFANRHFSA-N 10-methoxycamptothecin Chemical compound C1=C(OC)C=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 KLFJSYOEEYWQMR-NRFANRHFSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Chinese gallotannin Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- IOIGOIPHPUCFOB-UHFFFAOYSA-N Gentialutine Natural products C1=NC=C2C(C)C(O)CC2=C1 IOIGOIPHPUCFOB-UHFFFAOYSA-N 0.000 description 2
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 2
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 2
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- NDTNEAIKTSZYCF-XWNHBAMRSA-N [(1R,4aR,4bR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carbonyl] (1R,4aR,4bR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylate Chemical compound C([C@@H]1[C@@]2(C)CCC3)CC(C(C)C)=CC1=CC[C@H]2[C@]3(C)C(=O)OC(=O)[C@]1(C)CCC[C@@]2(C)[C@H]1CC=C1C=C(C(C)C)CC[C@@H]12 NDTNEAIKTSZYCF-XWNHBAMRSA-N 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 2
- KDKJYYNXYAZPIK-UHFFFAOYSA-J aluminum potassium disulfate hydrate Chemical compound O.[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O KDKJYYNXYAZPIK-UHFFFAOYSA-J 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 239000003716 antitrichomonal agent Substances 0.000 description 2
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 208000027503 bloody stool Diseases 0.000 description 2
- 238000001354 calcination Methods 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 210000001328 optic nerve Anatomy 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 2
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 2
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 239000003229 sclerosing agent Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- BZFBDUQOBQHBSZ-DLCQERRASA-N (3s,8r,9s,10r,13s,14s,17s)-17-[3-(dimethylamino)propyl-methylamino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol;dihydrochloride Chemical compound Cl.Cl.C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](N(C)CCCN(C)C)[C@@]1(C)CC2 BZFBDUQOBQHBSZ-DLCQERRASA-N 0.000 description 1
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- BTXXTMOWISPQSJ-UHFFFAOYSA-N 4,4,4-trifluorobutan-2-one Chemical compound CC(=O)CC(F)(F)F BTXXTMOWISPQSJ-UHFFFAOYSA-N 0.000 description 1
- PZVGVKOLTVKLNQ-UHFFFAOYSA-N 6-Deoxypseudoanisatin Natural products C1C(=O)OCC2(C)C(C)C(=O)CC31C(C)CC(O)C23O PZVGVKOLTVKLNQ-UHFFFAOYSA-N 0.000 description 1
- XREBTCQRSAHAHG-UHFFFAOYSA-N 6-deoxydunnianin Natural products CC1CC(OC(=O)c2ccccc2)C3(O)C4(C)COC(=O)CC13CC(O)C4C XREBTCQRSAHAHG-UHFFFAOYSA-N 0.000 description 1
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010000830 Acute leukaemia Diseases 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 206010065360 Anal prolapse Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- HAWSQZCWOQZXHI-UHFFFAOYSA-N CPT-OH Natural products C1=C(O)C=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 HAWSQZCWOQZXHI-UHFFFAOYSA-N 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- QZASCYZRXXOWEK-UHFFFAOYSA-N Dunnianin Natural products CC1CC(OC(=O)c2ccccc2)C3(O)C4(C)COC(=O)CC13CC(O)C4(C)O QZASCYZRXXOWEK-UHFFFAOYSA-N 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- HWGBHCRJGXAGEU-UHFFFAOYSA-N Methylthiouracil Chemical compound CC1=CC(=O)NC(=S)N1 HWGBHCRJGXAGEU-UHFFFAOYSA-N 0.000 description 1
- 206010061297 Mucosal erosion Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010034759 Petit mal epilepsy Diseases 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- LBRPLJCNRZUXLS-AZVRXDBZSA-N Vincosamide Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)[C@H](C[C@@H]2C3=C(C4=CC=CC=C4N3)CCN2C2=O)C2=CO1 LBRPLJCNRZUXLS-AZVRXDBZSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- NFGODEMQGQNUKK-UHFFFAOYSA-M [6-(diethylamino)-9-(2-octadecoxycarbonylphenyl)xanthen-3-ylidene]-diethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C1=C2C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C21 NFGODEMQGQNUKK-UHFFFAOYSA-M 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002223 anti-pathogen Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000008335 axon cargo transport Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- PZVGVKOLTVKLNQ-CQSFIRGISA-N chembl518321 Chemical compound C1C(=O)OC[C@@]2(C)[C@H](C)C(=O)C[C@@]31[C@H](C)C[C@H](O)[C@]23O PZVGVKOLTVKLNQ-CQSFIRGISA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000024207 chronic leukemia Diseases 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000001747 discharging ear Diseases 0.000 description 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- JQLDCCVJKRQUNE-ZREKMMHESA-N dunnianin Chemical compound C([C@@]1([C@@](C)(O)[C@H](O)CC23C[C@H]([C@@H]([C@@]21O)OC(=O)C3)C)C)OC(=O)C1=CC=CC=C1 JQLDCCVJKRQUNE-ZREKMMHESA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000010932 epithelial neoplasm Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229960002545 methylthiouracil Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000021368 organ growth Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 108700038606 rat Smooth muscle Proteins 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- VGTGOILROCHQGS-UHFFFAOYSA-N strictosidine lactam Natural products NC(CCC(=O)O)C(=O)OC1OC=C2C(CC3N(CCc4c3[nH]c5ccccc45)C2=O)C1C=C VGTGOILROCHQGS-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种治疗直肠脱垂,痔疮脱垂的外洗痔疮回托散。是纯中草配制而成,按照重量份数计及配伍:蜗牛粉,喜树果,荷叶蒂,老樟木,枯矾,松香粉,石榴皮,金樱子,五倍子,明矾。本发明的特点在于药物的合理配伍及其制备方法。本发明的优点在于,所使用的中药均符合中华人民共和国药典规定,药原料安全可靠,无毒无副作用,疗效,使用方便,避免手术痛苦。给不愿做手术患者及手术禁忌症者患解除病痛。值得临床及人民群众广泛使用。
Description
技术领域
本发明涉及一种纯中药外用制剂的痔疮回托散,具体涉及一种治疗直肠脱垂,痔疮脱出纯中药外用泡洗剂,痔疮回托散及制备方法。
背景技术
直肠脱垂,直肠壁部分或全层向下移位,称为直肠脱垂。直肠壁部分下移,即直肠黏膜下移,称黏膜脱垂或不完全脱垂;直肠壁全层下移称完全脱垂。若下移的直肠壁在肛管直肠腔内称内脱垂;下移到肛门外称为外脱垂。主要症状为有肿物自肛门脱出。初发时肿物较小,排便时脱出,便后自行复位。以后肿物脱出渐频,体积增大,便后需用手托回肛门内,伴有排便不尽和下坠感。最后在咳嗽、用力甚至站立时亦可脱出。随着脱垂加重,引起不同程度的肛门失禁,常有黏液流出,导致肛周皮肤湿疹、瘙痒。因直肠排空困难,常出现便秘,大便次数增多,呈羊粪样。黏膜糜烂,破溃后有血液流出。成人的黏膜脱垂多采用硬化剂注射治疗;成人的完全性直肠脱垂则以手术切除治疗为主。硬化剂注射治疗容易引起复发,远期疗效不理想。注射深度与剂量掌握不准,还引起严重并发症。而手术治疗费高,对身体组织有一定伤害,也不有一定复发率。综上所述情况,使得医者患者都不愿采取接受。
痔疮脱垂是指不能自动回缩的重度痔核,痔核脱出常是肛肠疾病痔疮,内痔和混合痔的Ⅱ期症状,多先有便血后有痔块脱垂,因晚期痔体增大,逐渐与肌层分离,排粪时被推出肛门外。轻者只在大便时脱垂,便后可自行回复,重者需用手推回,更严重者是稍加腹压即脱出肛门外,如咳嗽,行走等腹压微加重时,痔块就能脱出,回复困难,无法参加劳动。
现西医主要以手术分次切除为主,对组织损伤大,花费高,患者痛苦,多不愿接受。保守疗法,以内服补中益气中药为主补气固托,升提举陷。但收效慢,疗程长。
发明内容
根据以上现有技术的不足,本发明提供一种纯中药外洗散剂――痔疮回托散,并配合补中益气中药内服,提高了疗效,免除了手术的痛苦与恐惧心理,提高了保守治疗的治愈率,弘扬了祖国中医药学。满足大多数人保守治疗的意愿。
本发明所述的一种治疗直肠脱垂,痔疮脱垂的痔疮回托散。是纯中草配制而成,按照重量份数计及配伍,由以下中药原料配制:蜗牛粉8-15份,喜树果5-15份,荷叶蒂20-25份,老樟木20-25份,枯矾60――80份,松香粉5-15份,石榴皮8-15份,金樱子8-15份,五倍子20-25份,明矾60-80份,珍珠粉5-10份。
所述的一种治疗直肠脱垂,痔疮脱垂的痔疮回托散。是纯中草配制而成,按照重量份数计及配伍,由以下是纯中草药配制而成,其特征在于,步骤如下:蜗牛粉,喜树果,荷叶蒂,老樟木,枯矾,松香粉,石榴皮,金樱子,五倍子,明矾称量备份,用万能超细粉碎机粉碎成过200目细粉。分装,每袋分装成150克,备用。
用法用量:取本发明一袋150克,放入盆中,用开水冲泡化,特水温适宜不烫为度,患者将患处坐入水中,坐浴泡洗,每次10――15分钟,每日1-2次。痔疮或直肠回缩为止。
所述的一种治疗直肠脱垂,痔疮脱垂的痔疮回缩散。是纯中草配制而成,按照重量份数计及配伍,由以下是纯中草药配制而成,其特征在于,步骤如下:将选用活蜗牛,将其除杂、洗净,得新鲜蜗牛肉;将新鲜蜗牛肉在温度为0—45℃,真空度为0.09—0.095MPa,真空干燥8—20小时,使其水份含量降到5%以下;将干燥蜗牛肉粉碎制成蜗牛粗粉;将蜗牛粗粉投入超细粉碎机中粉碎。
枯矾炮制方法:1.白矾取原药材,除去杂质,捣碎或研细。2.枯矾取净白矾,敲成小块,置煅锅内,用武火加热至熔化,继续煅至膨胀松炮呈白色蜂窝状固体,完全干燥,停火,放凉后取出,研成细粉。煅制白矾时应一次性煅透,中途不得停火,不要搅拌。经搅拌后表面温度下降,结晶水不易除去,内热不断积蓄,传热性能降低,局部温度过高,而使白矾呈焦黄色。
蜗牛粉性味味咸,性寒,有小毒。功效主治主治跌打损伤,大肠下脱肛,筋急和惊痫;生研饮汁,止消渴;治各种肿毒痔漏。蜗壳功效主治主治一切疳疾,面上赤疮,久痢脱肛。蜗牛具有清热、解毒、消肿、治消渴等作用,对糖尿病、高血压、高血脂、气管炎、前列腺炎、恶疮和癌症等疾病有辅助治疗作用。功效;消肿疗疮,缩肛收脱,通利小便、应用与主治:治肿疗毒;治瘰病;治牙齿疼痛;。内含20多种氨基酸和10多种微量元素及丰富的蜗牛酶、SOD等。
喜树果化学成份]含喜树碱(camptothecine)、喜树次碱(venoterpine)、10—羟基喜树碱(10-hydroxycamptothecine)、10—甲氧基喜树碱(10—methoxycamptothecine)、白桦脂酸(betulicacid)、长春甙内酰胺(vincoside-lactam)等。性寒,味苦、涩;有毒。功能主治:喜树果还具有解毒散结,破血化瘀功效。用于各种癌症,急慢性白血病,银屑病及血吸虫引起的肝脾肿大。用于多种肿瘤,如胃癌、肠癌、绒毛膜上皮癌、淋巴肉瘤等。用量3—9g。
荷叶蒂:含莲碱、原荷叶碱及荷叶碱,[功能主治]清暑去湿,和血安胎。治血痢,泄泻,妊娠、胎动不安。内服:煎汤,15-20克;或入丸、散。外用:煎水洗。
老樟木;苦;辛;性温;祛风止痛;散瘀消肿。主风湿骨痛;跌打损伤;骨折。化学成份,皮中含6-去氧伪日本莽草素(6-deoxypseu-doanisatin),樟木钻素(dunnianin),6-去氧樟木钻素(6-deoxydun-nianin)。茎叶中含β-谷甾醇(β-sitosterol),1-三十烷醇(1-tria-contanol),槲皮甙(quercitrin),莽草酸(shikimicacid)药理作用;初步证实红花八角中莽草酸具有较强的镇痛作用,为本品的镇痛有效成分。红花八角醇提物也具有较强的镇痛作用,而且对5-HT等致炎有显着的抑制作。
枯矾:味酸涩而寒入肺、脾、胃、大肠经。,消痰,燥湿,止泻,止血,解毒,杀虫。治癫痫,喉痹,疚涎壅甚,肝炎,黄疸,黄肿,胃、十二指肠溃疡,子宫脱垂,白带,泻痢,衄血,口舌生疮,疮痔疥癣,水、火、虫伤。
药理作用:在180~260℃煅制的枯矾对变形杜菌、金黄色葡萄球菌、痢疾杆菌、绿脓杆菌的抑制作用与生品之间没有差异,300℃煅制品与生品之间有差异,500~900℃煅制品与生品之间均有显著差异,比生品抑菌作用显著降低。180~260℃煅制的枯矾对家兔眼结膜的刺激作用小。 按常规煅制的枯矾药液,对绿脓杆菌、金黄色葡萄球菌、溶血性链球菌、肺炎双球菌、大肠杆菌、霉菌等均呈现高度的敏感性。 白矾内服过量能刺激胃粘膜而引起反射性呕吐。至肠不吸收,适量制止肠粘膜分泌而起止泻作用。外用稀溶液能起消炎收敛防腐作用,溶液浸蚀肌肉引起溃烂。煅枯后形成难溶性铝盐,内服后可与粘膜蛋白络合,形成保护膜,覆盖于溃疡面上,保护粘膜不再受腐蚀,并有利于粘膜再生,还可抑制粘膜分泌和吸附肠异物,因此,枯矾消除了引吐作用,增强止血止泻作用。外用能和蛋白质化合而成难溶于水的蛋白质而沉淀,减少疮面渗出物而起生肌保护作用。
松香粉:苦、甘、温。归肝;脾经祛风燥湿,生肌止痛,适用于痈疖疮疡,湿疹,外伤出血,烧烫伤。5-10克,入丸散或浸酒服。外用适量,入膏药或研末敷患处。主要成分:为松香酸酐(abieticanhydride)及游离的松香酸(abieticacid),并含树脂烃、挥发油,主要为α-及β-蒎烯(Pinene)及小量左旋莰烯、二戊烯,还含槲皮素(quercetin)、山柰酚(kaempferol)的甙及苦味物质。
石榴皮:味酸、涩,性温。归大肠、肾经。质涩收敛。功效主治:涩肠止泻;止血;驱虫;痢疾;肠风下血;带下;害虫;创伤出血;脱肛;滑精;虫积腹痛;疥癣。久泻,便血,崩漏,鼻衄;中耳炎虫积腹痛。药理作用:1、收敛作用:石榴皮含多含糅质,当它们与粘膜、创面等接触后,能沉淀或凝固局部的蛋白质,使在表面形成较为致密的保,护层,有助于局部创面愈合或保护局部免受刺激。2、抗菌作用:石榴皮煎剂在试管内对志贺、施氏、福氏和宋内等4种痢疾杆菌均有抗菌作用,对志贺作用最强,施氏、福氏,次之,对宋内痢疾杆菌作用较差。比较400种中药对于伤寒杆菌、霍乱弧菌、葡萄球菌等的试管内杀菌力,证明石榴皮抑制,伤寒杆菌的作用最强。此外,体外实验证明对结核杆菌、大肠杆菌、变形杆菌、绿脓杆菌等多种细茵均有抑制作用。3、抗病毒作用:采用细胞,培养技术,证实糅质是石榴皮抗生殖器疮疹病毒的有效成分。其特点不仅能够抑制病毒在细胞内的增殖,更为重要的是显示。较强的直接杀灭病毒和阻止及吸附细胞的作用。4、驱虫作用:石榴皮煎剂有驱肠虫作用。其机理系作用于寄生虫的肌肉,使其陷于持续收缩,而具驱虫之效。5其他作用:从石榴皮甲醇提取物物分得一种化合物,对牛红细胞的碳酸酐酶活性有强的抑制作用。
金樱子:性味,酸涩;平;无毒。归经肾;膀胱;大肠;脾;肺经。功能主治:固精涩肠,缩尿止泻。治滑精,遗尿,小便频数,脾虚泻痢,肺虚喘咳,自汗盗汗,崩漏带下。药理作用1、对泌尿系统的影——金樱子水提物6g/kg灌胃,能使腹下神经制备尿频模型大鼠排尿次数减少,排尿间隔时间延长,每次排尿增多。2、对平滑肌的作用,金樱子水提取物能抑制家兔离体空肠平滑肌的自主收缩,拮抗乙酰胆碱、氯化钡引起的家兔空肠平滑肌、大鼠离体膀胱平滑肌的痉挛性收缩,拮抗去甲肾上腺素引起的家兔离体胸主动脉条收缩反应,对上述3种平滑肌的抑制作用均呈显着性的量效关系。3、对实验性动脉粥样硬化的作——家兔喂食胆甾醇并加适量甲基硫氧嘧啶以产生实验性动脉粥样硬化,用金樱子治疗2星期和3星期,血清胆甾醇分别降低12.5%和18.67%,脂蛋白于给药3星期后亦有明显下降。肝脏与心脏的脂肪沉着均较对照组轻微。粥样硬化程度也很轻微,对照组则十分严重。4、抗病原体作用,金樱子含鞣质,用平碟法作抑菌试验,25%根煎剂对金黄色葡萄球菌、大肠杆菌有很高的抑菌作用,对绿脓杆菌也有效。鸡胚试验证明,金樱子煎剂对流感病毒PR/8株抑制作用很强,而且对亚洲甲型57-4株、乙型Lee株、丙型1233株和丁型仙台株也有作用。
五倍子:酸、涩,寒。入肺、肾、大肠经敛肺,功能主治:涩肠,止血,解毒1.治肺虚久咳,久痢,久泻,咯血,衄血,便血,痔血,肾虚遗精,遗尿。煎服:1.5~4.5,2.研末敷脐治自汗,盗汗;煎水熏洗治脱肛,子宫脱垂;研末调敷治湿疮,鹅口疮,宫颈糜烂,疮疖肿毒,外伤出血。化学成份:盐肤木虫瘿主含五倍子鞣质。还含没食子酸、脂肪、树脂及腊质等。
明矾:酸、咸,涩,入肝肺二经。矾石之用有四:吐利风热之痰涎,取其酸苦涌泄也;治诸血痛,脱肛,阴挺,疮疡,。主治:中风;癫痫;喉痹;疥癣湿疮;痈疽肿毒;水火烫伤;口舌生疮;烂弦风眼;聤耳流脓;鼻中息肉;疮痔疼痛;崩漏;衄血;损伤出血;久泻玖痢;带下阴痒;脱肛;子宫下垂等。内服:入丸、散,0.2-1钱。外用:研末撒或调敷。1、抗菌作用 明矾对多种革兰阴性、阳性球菌和杆菌都有抑制作用;对常见化脓菌有较强抑菌作用。2、收敛、固脱作用,实验证明:明矾水具有很强的收敛作用.明矾内服刺激性很大,故多外用,可止汗;也可治疗白带过多及溃疡(浓度为1%~5%)。 3.抗阴道滴虫的作用10%明矾液在试管内(培养液与药液之比为1:1)有明显的抗阴道滴虫作用;4、其他作用 明矾与蛋白质相遇,使成难溶性的化合物而沉淀;明矾水在体外能使血清立即沉淀,有强烈凝固蛋白的作用;该品可用于止血,如鼻衄时可用棉球浸饱和的明矾溶液塞于鼻孔。
珍珠粉,味甘、咸,性寒;归心、肝经。安神定惊;清肝明目;解毒生肌。主惊悸怔仲;心烦失眠;惊风癫痫;目赤翳障;口舌生疮;咽喉溃腐;疮疡久不收口。1.增强免疫力珍珠粉含有亮氨酸、蛋氨酸、丙氨酸等18种氨基酸,氨基酸是淋巴组织器官生长、发育成熟所必需,且对细胞内蛋白质合成速率及合成蛋白质类型有明显影响。长期坚持内服珍珠粉能能有效提高人体免疫系统中的T、B淋巴细胞的活性,从而增强免疫抗病能力。2.补充钙质,珍珠粉中含有90-92%的活性钙,其中纯钙量达到38-40%。其次,钙的消化吸收率高,3.延缓衰老,珍珠粉本身含有的锰、铜、锌等三种微量元素是组成SOD的成分,用珍珠粉涂面,可促进人体肌肤超氧化物歧化酶(SOD)的活性,抑制黑色素的合成,保持皮肤白皙。此外,由于SOD具有清除自由基的作用,故用珍珠粉涂面可防止皮肤衰老、起皱。4.改善睡眠,据《本草纲目》记载"珍珠,镇心安魂魄",珍珠粉中含有多种氨基酸和微量元素能对大脑中枢起到“安抚与镇定”作用,人体吸收后就能使过度兴奋而导致疲劳的细胞得到滋养。5.防治口腔溃疡口腔溃疡是一种以周期性反复发作为特点的口腔粘膜局限性溃疡损害,可发生于口腔粘膜的任何部位,以唇、颊、舌部多见,严重者可以波及咽部粘膜。珍珠粉具有清热解毒,收敛伤口之效,特别的纳米珍珠粉的平均粒径细达40~100纳米,相当于毛孔的1/60,能够以最大的表面积与溃疡面接触,发挥其功效。同时珍珠粉有清胃火降心火之效,配合内服能够标本兼治。6.养肝明目珍珠粉有清热解毒之效,能够清肝火。肝主目,肝火旺则目生翳,视力模糊。珍珠粉中的硒可以强化视觉神经的传导,改善视力状况;微量元素中的锌可促进视神经的轴浆运输,改善视网膜及视网膜色素上皮细胞的代谢与功能。
本发明的优点在于,所使用的中药均符合中华人民共和国药典规定,药源料安全可靠,来自天然中药材,无毒无副作用,疗效佳,疗程短起效快,值得临床及人民群众广泛使用。本发明的特点在于药物的合理配伍
以下举几个典型病例:病例一,储XX,男,43岁,2001年8月就诊,安徽省岳西县。痔疮病史15余年,时轻时重,近几年大便时常脱出,开始能自动回缩,合并出血,疼痛脱垂。近一年发作更加严重,痔疮脱垂后不能自动回缩,要手指帮助托回,近一月发作脱出后,用手指也无法托回肛门内,经查视,环状内外混合痔Ⅲ期。当地医院要分多次手术。患者不愿接受。后用中医治疗,用本发明外洗一周,每天一次,每次一袋150克,用开水冲化坐浴15分钟。配合内中药‘消痔润肠散’(另一专利发明)。三天后环痔核回缩70%,一周后基本全部回缩肛门内,三周后大便时也不自动脱出。嘱多服补中益气之品,外洗痔疮回托散。避免重体力劳动。电访三年,有几次小发作,用同方医治而愈。未见大的复发。
病例二,刘XX,女,46岁。2005年3月就诊,安徽省太湖县,痔疮病史20年余,经当地市医院查为内、外环状痔Ⅲ期。症状,近几年大便后常脱出,时轻时重,有时要手指辅助上托,才能纳入肛门内。近20天发作后,手指辅助不能托回肛门内。伴有疼痛、出血,肿胀渗出。十分痛苦。。有严重心脏病与贫血病史,有手术禁忌症,无法手术。住院二周保守治未见好转。寻求中医治疗治,后用本发明(痔疮回托散)外洗坐浴,一次一袋150克,用开水冲泡,坐浴洗泡,每次15-20分钟,第天一次。配合内服中药‘消痔润肠散’(另一专利发明),一周后基本回缩60%,二周后基本无症状,痔核全部回缩于肛门内,大便时也再脱也。后用本发明巩固预防。回访五年未见复发。达到临床治愈。
病例三,王某,女,5岁。1999年8月就诊,主诉:反复便后肛内脱出肉状物6月余。现病史:患儿6月前因腹泻,每日6-8次,便后肛内脱出肉状物,当时可自行回纳,无粘液脓血便,未行系统检查及治疗,上症反复发作,未服用任何药物治疗,且脱出的肉状物不能自行回纳,需手托方可复位,家长不愿小儿手术治疗而就诊。门诊以“直肠脱垂”收住入院。入院时症见:便后肛内脱出肉状物,脱出的肉状物不能自行回纳,需手托方可复位,无粘液脓血便,小便调,食可眠安,精神良好。既往史平素体健,否认肝炎、结核、伤寒等传染病史,否认手术、外伤及输血史。预防接种史不详。过敏史否认药物及食物过敏史。中医治疗,用本发明痔疮回托散外洗坐浴,一天一次,一次一包150克,开水冲泡后,水温适宜而坐浴,每次5-10分钟,5天后脱出直肠粘膜全部回缩于肛门内,外不见任何脱垂物而出院。嘱平时注意护理。电访三年未见复发。
具体实施方式:以结合实施例对本发明做进一步说明本发明所述的一种治疗直肠脱垂,痔疮脱垂的痔疮回托散。是纯中草配制而成,按照重量份数计及配伍,由以下中药原料配制:蜗牛粉15份,喜树果15份,荷叶蒂25份,老樟木25份,枯矾80份,松香粉15份,石榴皮15份,金樱子15份,五倍子25份,明矾80份,珍珠粉10份。
本发明所述的一种治疗直肠脱垂,痔疮脱垂的痔疮回托散。是纯中草配制而成,按照重量份数计及配伍,由以下中药原料配制:蜗牛粉8份,喜树果5份,荷叶蒂25份,老樟木25份,枯矾80份,松香粉5,石榴皮15份,金樱子8,五倍子25份,明矾80份,珍珠粉5份。
以上对本发明的具体描述,旨在说明具体实施方案的实现方式,不能理解为是对本发明的限制,本领域普通枝术人员在本发明的教导与启发下,要以在详述的实施方案的基础上做出各种变体、润饰,与剂型、变通,这些变体、润饰,与剂型、变通均应包含在本发明的构思之内。本发明所要示保护的范围由所述的权利要求书进行限制。
Claims (8)
1.一种治疗直肠脱垂,痔疮脱垂的痔疮回托散;是纯中草配制而成,按照重量份数计及配伍,由以下中药原料配制:蜗牛粉8-15份,喜树果5-15份,荷叶蒂20-25份,老樟木20-25份,枯矾60――80份,松香粉5-15份,石榴皮8-15份,金樱子8-15份,五倍子20-25份,明矾60-80份,珍珠粉5-10份1。
2.根据权利要求1所述,一种治疗直肠脱垂,痔疮脱垂的痔疮回托散;是纯中草配制而成,按照重量份数计及配伍,由以下是纯中草药配制而成,其特征在于,步骤如下:蜗牛粉,喜树果,荷叶蒂,老樟木,枯矾,松香粉,石榴皮,金樱子,五倍子,明矾称量备份,用万能超细粉碎机粉碎成过200目细粉,分装,每袋分装成150克,备用2。
3.根据权利要求1所述,一种治疗直肠脱垂,痔疮脱垂的痔疮回托散,用法用量:取本发明一袋150克,放入盆中,用开水冲泡化,特水温适宜不烫为度,患者将患处坐入水中,坐浴泡洗,每次10――15分钟,每日1-2次3。
4.根据权利要求1所述,一种治疗直肠脱垂,痔疮脱垂的痔疮回托散,其特征在于,步骤如下:将选用活蜗牛,将其除杂、洗净,得新鲜蜗牛肉;将新鲜蜗牛肉在温度为0—45℃,真空度为0.09—0.095MPa,真空干燥8—20小时,使其水份含量降到5%以下;将干燥蜗牛肉粉碎制成蜗牛粗粉;将蜗牛粗粉投入超细粉碎机中粉碎4。
5.根据权利要求1所述,一种治疗直肠脱垂,痔疮脱垂的痔疮回托散,枯矾炮制方法:枯矾取净白矾,敲成小块,置煅锅内,用武火加热至熔化,继续煅至膨胀松炮呈白色蜂窝状固体,完全干燥,停火,放凉后取出,研成细粉;煅制白矾时应一次性煅透,中途不得停火,不要搅拌;经搅拌后表面温度下降,结晶水不易除去,内热不断积蓄,传热性能降低,局部温度过高,而使白矾呈焦黄色5。
6.根据权利要求1所述,一种治疗直肠脱垂,痔疮脱垂的痔疮回托散,按照重量份数计及配伍,由以下中药原料配制:蜗牛粉15份,喜树果15份,荷叶蒂25份,老樟木25份,枯矾80份,松香粉15份,石榴皮15份,金樱子15份,五倍子25份,明矾80份,珍珠粉10份6。
7.根据权利要求1所述,一种治疗直肠脱垂,痔疮脱垂的痔疮回托散,是纯中草配制而成,按照重量份数计及配伍,由以下中药原料配制:蜗牛粉8份,喜树果5份,荷叶蒂25份,老樟木25份,枯矾80份,松香粉5,石榴皮15份,金樱子8,五倍子25份,明矾80份,珍珠粉5份7。
8.所述一种治疗直肠脱垂,痔疮脱垂的痔疮回托散,以上对本发明的具体描述,旨在说明具体实施方案的实现方式,不能理解为是对本发明的限制,本领域普通枝术人员在本发明的教导与启发下,要以在详述的实施方案的基础上做出各种变体、润饰,与剂型、变通,这些变体、润饰,与剂型、变通均应包含在本发明的构思之内;本发明所要求保护的范围由所述的权利要求书进行限制8。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510911960.8A CN105287787A (zh) | 2015-12-11 | 2015-12-11 | 治疗直肠痔疮脱垂回托散及制备方法 |
PCT/CN2016/105536 WO2017097089A1 (zh) | 2015-12-11 | 2016-11-12 | 直肠脱垂方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510911960.8A CN105287787A (zh) | 2015-12-11 | 2015-12-11 | 治疗直肠痔疮脱垂回托散及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105287787A true CN105287787A (zh) | 2016-02-03 |
Family
ID=55186074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510911960.8A Pending CN105287787A (zh) | 2015-12-11 | 2015-12-11 | 治疗直肠痔疮脱垂回托散及制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN105287787A (zh) |
WO (1) | WO2017097089A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017097089A1 (zh) * | 2015-12-11 | 2017-06-15 | 黄建民 | 直肠脱垂方 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102451263A (zh) * | 2010-10-27 | 2012-05-16 | 赵欣 | 一种治疗直肠脱垂的中药配方 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105287660A (zh) * | 2014-06-27 | 2016-02-03 | 陈爱莲 | 用于治疗脱肛的熏洗剂 |
CN105287787A (zh) * | 2015-12-11 | 2016-02-03 | 黄建民 | 治疗直肠痔疮脱垂回托散及制备方法 |
-
2015
- 2015-12-11 CN CN201510911960.8A patent/CN105287787A/zh active Pending
-
2016
- 2016-11-12 WO PCT/CN2016/105536 patent/WO2017097089A1/zh active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102451263A (zh) * | 2010-10-27 | 2012-05-16 | 赵欣 | 一种治疗直肠脱垂的中药配方 |
Non-Patent Citations (1)
Title |
---|
敏涛等: "《精选妙用中草药治疗常见外科疾病》", 30 June 2006, 江西科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017097089A1 (zh) * | 2015-12-11 | 2017-06-15 | 黄建民 | 直肠脱垂方 |
Also Published As
Publication number | Publication date |
---|---|
WO2017097089A1 (zh) | 2017-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101884770B (zh) | 治疗尿石症的中药制剂及其制备方法 | |
CN104366636B (zh) | 一种平卧菊三七复合制剂及制备方法及应用 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN103877247B (zh) | 用于治疗褥疮的药物及其制备方法 | |
CN103536826B (zh) | 一种治疗阴道炎的中药组合物及其制备方法 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN104815192A (zh) | 一种治疗高血压的药物组合物及其应用 | |
CN106974952A (zh) | 鲜人参活性提取物在制备治疗口腔及消化道溃疡药物中的应用 | |
CN104324125B (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
CN103893613B (zh) | 一种治疗口腔溃疡的药物及制备方法 | |
CN103083690A (zh) | 一种用于胃肠彩色超声造影的胶囊剂 | |
CN102940831A (zh) | 一种用于抑菌与治疗妇科炎症的外用泡腾片 | |
CN106389881A (zh) | 一种活血散瘀膏 | |
CN105770597A (zh) | 一种用于治疗胃溃疡的药物制剂 | |
CN110038111A (zh) | 一种用于治疗慢性萎缩性胃炎的中药膏方制剂及其制备方法 | |
CN105287787A (zh) | 治疗直肠痔疮脱垂回托散及制备方法 | |
CN103920016A (zh) | 一种治疗慢性咽喉炎的中药茶饮 | |
CN1277573C (zh) | 一种治疗口腔溃疡的药物 | |
CN103041091B (zh) | 一种预防或治疗腹部外科手术后腹胀的药物组合物 | |
CN113491755A (zh) | 治疗宫颈hpv感染的联合用药方剂 | |
CN105617275A (zh) | 一种用于治疗急性膀胱炎的中药制剂及制备方法 | |
CN105232849A (zh) | 一种治疗烧伤的膏药 | |
CN103520653B (zh) | 一种治疗胃癌的中药组合物 | |
CN104055900A (zh) | 一种治疗荨麻疹的中药组合物 | |
CN102657789A (zh) | 一种幼犬传染性肝炎的中药方剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160203 |